First line therapy for Helicobacter pylori eradication in France;Comment éradiquer Helicobacter pylori en première intention en France?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 3 II, 2003, Pages 467-472

  Dupas, Jean Louis ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFICACY; ERADICATION THERAPY; FRANCE; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; PRESCRIPTION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FRANCE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PENICILLINS; PRACTICE GUIDELINES; RECURRENCE;

EID: 0037362149     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Conférence de Consensus: maladie ulcéreuse et gastrites à l'heure d'Helicobacter pylori (texte long). Gastroenterol Clin Biol 1996;20:S155-62.
2. Cayla R. Comment éradiquer Helicobacter pylori? Gastroenterol Clin Biol 1996;20:S119-30.
3. Deltenre M, De Koster E, Caucheteur B, Otero J, Jonas C. Comment éradiquer Helicobacter pylori en 1995. Revue critique des traitements disponibles. Gastroenterol Clin Biol 1996;20:S44-S52.
4. Lind T, Veldhuyzen VZ, Unge P, Spiller R, Bayerdorffer E, O'Morain C et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 Study. Helicobacter 1996;1:138-44.
5. Bigard MA, Delchier JC, Riachi G, Thibault P, Barthélemy P. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther 1998;12:383-8.
6. Ruszniewski P, Lamouliatte H, Fléjou JF, Mégraud F, Slama A. Evaluation of short-term ranitidine versus omeprazole triple therapy regimens for eradication of Helicobacter pylori in duodenal ulcer patients (abstract). Gut 1997;41(suppl 1):A94.
7. Lamouliatte H, Samoyeau R, De Mascarel A, Mégraud F. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1999;13:1523-30.
8. Laurent J, Mégraud F, Flejou JF, Caekaert A, Barthélemy P. A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Phannacol Ther 2001;15:1787-93.
9. Tankovic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Aliment Pharmacol Ther 2001;15:707-13.
10. Tchamgoué S, Broutet N, Nachit F, Lamouliatte H, Mégraud F. Facteurs d'échec de l'éradication de Helicobacter pylori dans les essais cliniques multicentriques menés en France (abstract). Gastroenterol Clin Biol 2000;24(suppl 2 bis):A138.
11. Delchier JC, Roudot-Thoraval F, Courillon-Mallet A, Lamouliatte H, Brousse JF, Bretagne JF et al. Traitement de l'infection à Helicobacter pylori en pratique courante: résultats d'une enquête multicentrique nationale (abstract). Gastroenterol Clin Biol 2001;25(suppl 2 bis):A8.
12. Della MP, Lavagna A, Masoero G, Lombardo L, Crocella L, Pera A. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy. Aliment Pharmacol Ther 2002;16:1269-75.
13. Lee JM, Breslin NP, Hyde DK, Buckley MJ, O'Morain CA. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999;13:489-96.
14. Conférence de Consensus Helicobacter pylori - Révision 1999. Conclusions et recommandations révisées du groupe de travail. Gastroenterol Clin Biol 1999;23:C95-104.
15. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A et al. Current concepts in the management of Helicobacter pylori infection- the Maastricht 2-2000 Consensus Report.
16. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997;41:8-13.
17. Peura D. Helicobacter pylori: rational management options. Am J Med 1998;105:424-30.
18. Unge P. Antimicrobial treatment of H. pylori infection - a pooled efficacy analysis of eradication therapies. Eur J Surg 1998;164 (suppl 582):16-26.
19. Vaira D, Ali A, Gatta L, O'Morain C. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 1998;14(suppl 1):S71-8.
20. Pipkin GA, Williamson R, Wood JR. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998;12:823-37.
21. Houben MH, van de BD, Hensen EF, Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy- the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999;13:1047-55.
22. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection-a meta-analysis. Aliment Pharmacol Ther 1999;13:857-64.
23. Gisbert JP, Gonzalez L, Calvet X, Garcia N, Lopez T, Roque M et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14:1319-28.
24. Mégraud F, Marshall BJ. How to treat Helicobacter pylori. First-line, second-line, and future therapies. Gastroenterol Clin North Am 2000;29:759-73, vii.
25. Miehlke S, Bayerdorffer E, Graham DY. Treatment of Helicobacter pylori infection. Semin Gastrointest Dis 2001;12:167-79.
26. Guslandi M. Review article: alternative antibacterial agents for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001;15:1543-7.
27. Vallve M, Vergara M, Gisbert JP, Calvet X. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Ther 2002;16:1149-56.
28. Qasim A, O'Morain CA. Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther 2002;16 Suppl 1:24-30.
29. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
30. Dupas JL, Corallo J, Helbert T, Zaim M. La poursuite du traitement antisécrétoire après trithérapie d'éradication de Helicobacter pylori n'est pas nécessaire pour obtenir la cicatrisation des ulcères duodénaux. Gastroenterol Clin Biol 2000;24:638-43.
31. Bruley des Varannes S, Flejou JF, Colin R, Zaïm M, Meunier A. Eradication d'H. pylori dans la dyspepsie non ulcéreuse: résultats d'un essai contrôlé randomisé, double aveugle à un an (abstract). Gastroenterol Clin Biol 2000;24(suppl 2 bis):A42.
32. Ell C, Schoerner C, Solbach W, Stolte M, Vieth M, Ridl W et al. The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 2001;13:685-91.
33. Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Helicobacter pylori eradication: proton pump inhibitor vs ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. Aliment Pharmacol Ther 2000;14:1141-50.
34. Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000;95:3393-8.
35. Lind T, Mégraud F, Unge P, Bayerdorffer E, O'Morain C, Spiller R et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999;116:248-53.
36. Veldhuyzen VZ, Lauritsen K, Delchier JC, Labenz J, De Argila CM, Lind T et al. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 2000;14:1605-11.
37. Lamouliatte H, Perie F, Joubert-Collin M. Traitement de l'infection par Helicobacter pylori par lansoprazole 30 mg ou 60 mg associé à deux antibiotiques chez les ulcéreux duodénaux. Gastroenterol Clin Biol 2000;24:495-500.
38. Catalano F, Branciforte G, Catanzaro R, Bentivegna C, Cipolla R, Nuciforo G et al. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. Helicobacter 1999;4:178-84.
39. Bardhan KD, Dillon J, Axon AT, Cooper BT, Tildesley G, Wyatt JI et al. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. Aliment Pharmacol Ther 2000;14:59-67.
40. Miwa H, Yamada T, Sato K, Ohta K, Ohkura R, Murai T et al. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. Dig Dis Sci 2000;45:77-82.
41. Pilotto A, Malfertheiner P. Review article: an approach to Helicobacter pylori infection in the elderly. Aliment Pharmacol Ther 2002;16:683-91.
42. Lehmann FS, Drewe J, Terracciano L, Beglinger C. Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 2000;14:305-9.
43. Wolle K, Leodolter A, Malfertheiner P, Konig W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002;51:705-9.
44. Bazzoli F, Zagari RM, Mégraud F et al. Antimicrobial resistance of Helicobacter pylori in a large population of duodenal ulcer patients in Italy (abstract). Gastroenterology 2000;118(suppl 2):A 2652.
45. Mégraud F, Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 1998;43 Suppl 1:S61-5.
46. Broutet N, Guillou F, Sauty E et al. Survey of the in vitro susceptibility of Helicobacter pylori to antibiotics in France: preliminary results (abstract). Gut 1998;43(suppl 2):A11.
47. Bardhan K, Bayerdorffer E, Veldhuyzen Van Zanten SJ, Lind T, Mégraud F, Delchier JC et al. The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter 2000;5:196-201.
48. Pilotto A, Leandro G, Franceschi M, Rassu M, Bozzola L, Furlan F et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999;13:667-73.
49. Toracchio S, Cellini L, Di Campli E, Cappello G, Malatesta MG, Ferri A et al. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:1639-43.
50. Guslandi M. Review article: alternative antibacterial agents for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001;15:1543-7.
51. Perri F, Festa V, Merla A, Quitadamo M, Clemente R, Andriulli A. Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. Helicobacter 2002;7:99-104.
52. Cammarota G, Papa A, Cianci R, Cannizzaro O, Armuzzi A, Gasbarrini A et al. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. Eur J Gastroenterol Hepatol 1999;11:247-50.
53. Calabrese C, Di Febo G, Areni A, Scialpi C, Biasco G, Miglioli M. Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:1613-7.
54. Cammarota G, Cianci R, Cannizzaro O, Cuoco L, Pirozzi G, Gasbarrini A et al. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:1339-43.
55. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:603-9.
56. Calvet X, Gene E, Lopez T, Gisbert JP. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. Aliment Pharmacol Ther 2001;15:1067-76.
57. Gisbert JP, Marcos S, Gisbert JL, Pajares JM. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 2001;13:1303-7.
58. Broutet N, Marais A, Lamouliatte H, De Mascarel A, Samoyeau R, Salamon R et al. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol 2001;39:1319-22.
59. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of failure of Helicobacter pylori eradication with the standard "Maastricht triple therapy". Aliment Pharmacol Ther 2001;15:1023-9.
60. Bommelaer G, Bruley D, V, Flejou JF, Matysiak T, Poynard T, Richard A et al. Statut cagA et virulence des souches de Helicobacter pylori. Résultats d'une étude multicentrique prospective française. Gastroenterol Clin Biol 2001;25:1084-9.
61. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Jr., Klein PD et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
62. Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol 2002;26:216-9.
63. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070-5.
64. Moayyedi P, Chalmers DM, Axon AT. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1997;32:24-7.
65. van der WJ, Steijns LS. Cytochrome P450 enzyme system: genetic polymorphisms and impact on clinical pharmacology. Ann Clin Biochem 1999;36 (Pt 6):722-9.
66. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36:425-38.
67. Parsons HK, Carter MJ, Sanders DS, Winstanley T, Lobo AJ. Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther 2001;15:1473-8.